Corneal Collagen Cross-Linking (CXL)
Corneal Cross-Linking (CXL)
This patient-education article is written by the cornea service at Suraj Eye Institute, Nagpur.
What is Corneal Cross-Linking?
Corneal collagen cross-linking (CXL, sometimes called C3R) is a one-time outpatient procedure that strengthens the cornea. It is the only treatment that has been shown to halt the progression of keratoconus and of post-refractive ectasia. CXL does not reverse the deformity that has already occurred — it stops the disease from getting worse.
How CXL Works
The cornea gets its mechanical strength from a regular lattice of type-I collagen fibres. In keratoconus this lattice is biomechanically weak and the cornea slowly bulges forward. CXL strengthens the lattice by creating new chemical bonds (cross-links) between the collagen fibres. The procedure has two ingredients:
- Riboflavin (vitamin B2) drops applied to the cornea after the surface epithelium is removed
- Ultraviolet-A light shone on the riboflavin-soaked cornea
The riboflavin absorbs the UV-A and generates reactive oxygen species that crosslink adjacent collagen fibres — the cornea becomes biomechanically stiffer within days.
Indications
- Progressive keratoconus — the commonest indication. Progression is confirmed on serial Anterion swept-source OCT tomography
- Post-refractive ectasia after LASIK, SMILE or PRK
- Pellucid marginal degeneration and other peripheral ectasias
- Corneal melting and infectious keratitis unresponsive to standard treatment (PACK-CXL)
Protocols
- Standard (Dresden) epi-off CXL — epithelium removed, riboflavin drops for 30 minutes, UV-A for 30 minutes at 3 mW/cm². The original and best-evidenced protocol.
- Accelerated CXL — higher UV-A irradiance (9 mW/cm² or 18 mW/cm²) for a shorter time (10–5 minutes). Comparable outcomes in most studies; shorter chair-time.
- Epithelium-on (transepithelial) CXL — the epithelium is not removed. Less painful but lower efficacy; reserved for selected paediatric or thin-cornea cases.
What to Expect
CXL is performed under topical anaesthetic and takes 30–60 minutes per eye. A soft bandage contact lens is worn for the first week while the epithelium heals. Vision is blurred and the eye is light-sensitive for several days. Most patients return to normal activities by 7–10 days.
We offer standard epi-off and accelerated cross-linking for progressive keratoconus, post-LASIK ectasia and pellucid marginal degeneration. Eligibility is decided on serial Anterion swept-source OCT tomography and corneal thickness, and the procedure is followed by structured 1-, 6- and 12-month review to confirm stability.
Frequently Asked Questions
